ADVISORY: The 5th European Biotechnology Symposium ``Realizing the Potential of Biotechnology''.News/Assignment Editors, Health, Medical & High-Tech high-tech also hi-tech adj. Informal Of, relating to, or resembling high technology. high-tech Adjective same as hi-tech Adj. 1. Writers ADVISORY... for Sunday Sunday: see Sabbath; week. (Sept. 29) BIOWIRE2K --(BUSINESS WIRE) Last chance to register for this symposium symposium In ancient Greece, an aristocratic banquet at which men met to discuss philosophical and political issues and recite poetry. It began as a warrior feast. Rooms were designed specifically for the proceedings. and join this symposium which will be attended by senior managers of biopharmaceutical companies and pharmaceutical companies. The 5th European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. Biotechnology Symposium runs 29 September September: see month. - October October: see month. 1st at the Bayerischer Hof Hof (hōf), city (1994 pop. 52,720), Bavaria, E central Germany, on the Saale River, near the Czech border. The city's industries produce textiles, beer, and machinery. Hof was first mentioned in the early 13th cent. Hotel in Munich, during the world famous Octoberfest. This symposium presented by Genetic Engineering News, will address issues facing emerging and established European Companies It may never be fully completed or, depending on its its nature, it may be that it can never be completed. However, new and revised entries in the list are always welcome. This is a list of companies from the countries in the European Union. developing and manufacturing biopharmaceuticals, and cover new technological developments and provides an opportunity to gain a pan-European view of the industry and its business environment with the emphasis on "Realizing the Potential of Biotechnology".
What: The 5th European Biotechnology Symposium - "Realizing the
Potential of Biotechnology"
When: September 29 - October 1, 2002. Opening 6:00 PM Sunday
concluding 5:30 PM Tuesday
Where: Bayerischer Hof Hotel, Munich, Germany - Phone: + 49 (0) 90
2120-0
Who:
Dr. Tony Bradshaw, Programme Chair, Head of Healthcare, Harvey
Nash
John Sterling, Managing Editor Genetic Engineering News
James Chistie, Protherics PLC - Global Biomanufacturing
Developments
John Brown, Integrated Biosystems - Biomanufacturing Operations
Crawford Brown, Eden BioPharm - Novel Expression Systems and
Process Development
Dr. Anthony Lucas, Biovectra dcl - Technology Innovations
Dr. Linda B. Hakes, Schwarz BioSciences - Product Formulation and
Delivery
David Thatcher, Cobra Therapeutics and Sharon Redmond, Celltech -
Moving Products from Research through Development and into
Manufacturing
Dr. Stephen C. Taylor, Chair of BioIndustry Association - Regional
Biomanufacturing Initiatives
Sponsors:
Host - Bavarian Ministry for Economic Affairs
Diamond - Charter Medical Ltd and Roche Diagnostics GmbH
Gold - Serologicals Corporation
Silver - Accentus, BioInvent Production AB, BioProtein
Technologies, BioReliance Limited, Covance, Disynyth RTOP, Inc.,
Excell Biotech, Greenovation Biotech GmbH, Integrated Systems, JRH
Biosciences, Millipore Corporation, Pall Life Sciences, Perbio
Science, Q One Biotech, Scottish Enterprise Edinburgh & Lothian,
Spectrum Europe BV, Stedim and Genetic Engineering News.
Organizers: Bioconferences International, Inc.
(www.bioconferences.com) 800-5-BIOCON
Details: For complete program and registration, visit the web site
http://www.bioconferences.com/ebs.
Limited press attendance. For press credentials please call or
e-mail:
BioConferences International, Inc.
Harriet I. Matysko, Senior Vice President
914-834-3100, ext. 608
Hmatysko@Liebertpub.com.
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion